A May 2020 Nature Communications study, co-authored by Jackson, showed that ACE2 — the classic SARS-CoV-2-binding cell-surface molecule, or receptor — concentrates on the cilia of nasal ...

This development could be associated with damage to nasal and brain cells. Goblet cell targets of SARS-CoV-2. ... Mucus reduction could also cause strange sensations in the nasal cavity, ...

Two specific nose cell types have been identified as likely initial infection points for COVID-19 coronavirus. Scientists discovered that goblet and ciliated cells in the nose have high levels of ...

SEATTLE, July 15, 2020 -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of.

The effect of PNN on nasal secretions was first determined by examining the characteristics of the nasal glands and goblet cells. Posterior nasal neurectomy induced hypertrophic and metaplastic ...

The highest concentration of ACE-2 in your nose is found in mucus-producing goblet cells and ciliated epithelial cells, which are cells that line the tract of your nasal cavity.

Using existing and new data, the Cell study looked at multiple human, primate and mouse tissues. This study also found that nasal goblet cells highly express ACE2. In addition, researchers found ...

The air that enters the nasal cavity flows down the trachea. The trachea has a number of adaptations: ... ciliated epithelium and goblet cells to clean the air before it reaches the lungs; ...

Results from the Phase 2 IMPERIAL study illustrate OC-01 nasal spray caused a decrease in goblet cell size, as compared to placebo, indicating mucin secretion after a single administration ...

Researchers map SARS-CoV-2 infection in cells of nasal cavity, bronchia, lungs. ScienceDaily. Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2020 / 06 / 200601194139.htm.